Select Medical
SEM was delisted on the 30th of June, 2026.
218 hedge funds and large institutions have $1.55B invested in Select Medical in 2020 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 82 increasing their positions, 63 reducing their positions, and 38 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 63
11% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 38
0.63% more ownership
Funds ownership: 76.38% → 77.01% (+0.63%)
0% more funds holding
Funds holding: 217 → 218 (+1)
35% less capital invested
Capital invested by funds: $2.39B → $1.55B (-$840M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
61% less call options, than puts
Call options by funds: $868K | Put options by funds: $2.25M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$14M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$12.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$12.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.91M |
| 5 |
Renaissance Technologies
New York
|
+$8.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$48.6M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$11.6M |
| 3 |
Millennium Management
New York
|
-$11M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$10M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6.8M |
SEM Hedge Fund Activity: Q1 2020 in Review
218 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2020, worth a combined $1.55B — down 35% from $2.39B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new SEM positions and 38 closed out — a net gain of 4 holders — while 82 added to existing stakes and 63 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $14M. The largest seller was T. Rowe Price Associates, cutting an estimated $48.6M.
- 218 institutional investors held Select Medical (SEM) as of Q1 2020, up from 217 in Q4 2019.
- Funds reported $1.55B of Select Medical stock for Q1 2020, down 35% quarter-over-quarter.
- 42 funds opened new Select Medical positions in Q1 2020 and 38 closed out, a net change of +4 holders.
- The largest Select Medical buyer in Q1 2020 was Goldman Sachs, an estimated $14M added.
- The largest Select Medical seller in Q1 2020 was T. Rowe Price Associates, an estimated $48.6M sold.
Based on aggregated 13F filings for Q1 2020.